RenovoRx, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 1.08 million compared to USD 3.26 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.36 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.13 USD | -1.31% |
|
-17.52% | -50.66% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.66% | 27.42M | |
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |
- Stock Market
- Equities
- RNXT Stock
- News RenovoRx, Inc.
- RenovoRx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024